retatrutide investigational drug triple hormone receptor agonist A review of an retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology Retatrutide, a new weight loss
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6



























